A possible role for progesterone metabolites in human parturition

Australian and New Zealand Journal of Obstetrics and Gynaecology

Volumn 46, Issue 2, 2006, Pages 159-163

  Sheehan, Penelope M ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Human; Parturition; Progesterone; Progesterone metabolites

Indexed keywords

20ALPHA DIHYDROPROGESTERONE; 5ALPHA PREGNANE 3,20 DIONE; HYDROXYPROGESTERONE CAPROATE; MIFEPRISTONE; OXYTOCIN; PLACEBO; PREGNANEDIONE; PROGESTERONE; PROGESTERONE RECEPTOR; RICINOLEIC ACID; STEROID 5ALPHA REDUCTASE;

CHILDBIRTH; CLINICAL TRIAL; CONFORMATIONAL TRANSITION; DRUG EFFICACY; DRUG MECHANISM; DRUG METABOLISM; DRUG RESPONSE; ENZYME ACTIVITY; FEMALE; GESTATION PERIOD; HIGH RISK POPULATION; HORMONAL REGULATION; HUMAN; LUTEAL PHASE; MOLECULAR MECHANICS; NONHUMAN; PREGNANCY; PREMATURE LABOR; PRIORITY JOURNAL; PROGESTERONE METABOLISM; RECEPTOR BINDING; REVIEW; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; UTERUS CONTRACTILITY; UTERUS CONTRACTION;

17-ALPHA-HYDROXYPROGESTERONE; 5-ALPHA-DIHYDROPROGESTERONE; ADULT; BIOLOGICAL MARKERS; FEMALE; GESTATIONAL AGE; HUMANS; LABOR ONSET; MATERNAL AGE; OBSTETRIC LABOR, PREMATURE; PARITY; PARTURITION; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY OUTCOME; PROGESTERONE; RANDOMIZED CONTROLLED TRIALS; SENSITIVITY AND SPECIFICITY;

EID: 33645356692     PISSN: 00048666     EISSN: 1479828X     Source Type: Journal    
DOI: 10.1111/j.1479-828X.2006.00548.x     Document Type: Review

References (41)

1. Csapo AI, Knobil E, van der Molen HJ, Wiest WG. Peripheral plasma progesterone levels during human pregnancy and labor. Am J Obstet Gynecol 1971; 110: 630-632.
2. Turnbull AC, Patten PT, Flint AP, Keirse MJ, Jeremy JY, Anderson AB. Significant fall in progesterone and rise in oestradiol levels in human peripheral plasma before onset of labour. Lancet 1974; 1: 101-103.
3. Coats P, Florensa E, Youssefnejadian E, Craft I. Plasma steroids in the foetal and maternal circulation at normal delivery and elective Caesarean section. Acta Obstet Gynecol Scand 1978; 57: 121-124.
4. Farquharson RG, Klopper AI. Progesterone concentrations in maternal and fetal blood. Br J Obstet Gynecol 1984; 91: 133-137.
5. Maynard PV, Heyes VM, Shaxted EJ. Plasma progesterone in the umbilical vessels at vaginal delivery of term infants. Br J Obstet Gynaecol 1982; 89: 989-993.
6. Mesiano S, Chan EC, Fitter JT, Kwek K, Yeo G, Smith R. Progesterone withdrawal and estrogen activation in human parturition are coordinated by progesterone receptor A expression in the myometrium. J Clin Endocrinol Metab 2002; 87: 2924-2930.
7. Dong X, Shylnova O, Challis JR, Lye SJ. Identification and characterization of the protein-associated splicing factor as a negative co-regulator of the progesterone receptor. J Biol Chem 2005; 280: 13329-13340.
8. Frydman R, Lelaidier C, Baton-Saint-Mleux C, Fernandez H, Vial M, Bourget P. Labor induction in women at term with mifepristone (RU 486): a double-blind, randomized, placebo-controlled study. Obstet Gynecol 1992; 80: 972-975.
9. Lelaidier C, Baton C, Benifla JL, Fernandez H, Bourget P, Frydman R. Mifepristone for labour induction after previous caesarean section. Br J Obstet Gynaecol 1994; 101: 501-503.
10. Chwalisz K, Fahrenholz F, Hackenberg M, Garfield R, Elger W. The progesterone antagonist onapristone increases the effectiveness of oxytocin to produce delivery without changing the myometrial oxytocin receptor concentrations. Am J Obstet Gynecol 1991; 165: 1760-1770.
11. da Fonseca E, Bittar R, Carvalho M, Zugaib M. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: A randomized placebo-controlled double-blind study. Am J Obstet Gynecol 2003; 188: 419-424.
12. Meis PJ, Klebanoff M, Thom E et al. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. [see comment] [erratum appears in N Engl J Med 2003; 349: 1299]. N Engl J Med 2003; 348: 2379-2385.
13. Brancazio LR, Murtha AP, Heine RP. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. [comment]. N Engl J Med. 2003; 349: 1087-1088.
14. Keirse MJ. Progesterone and preterm: Seventy years of 'deja vu' or 'still to be seen'? [comment]. Birth 2004; 31: 230-235.
15. Meis PJ, Society for Maternal-Fetal M. 17 hydroxyprogesterone for the prevention of preterm delivery. Obstet Gynecol 2005; 105: 1128-1135.
16. Dodd JM, Crowther CC, Cincotta R, Flenady V, Robinson JS. Progesterone supplementation for preventing preterm birth: A systematic review and meta-analysis. Acta Obstet Gynecol Scand 2005; 84: 526-533.
17. Milewich L, Gant NF, Schwarz BE et al. Initiation of human parturition. VI. Identification and quantification of progesterone metabolites produced by the components of human fetal membranes. J Clin Endocrinol Metab 1977; 45: 400-411.
18. Milewich L, Gomez-Sanchez C, Madden JD, MacDonald PC. Isolation and characterization of 5alpha-pregnane-3,20-dione and progesterone in peripheral blood of pregnant women: Measurement throughout pregnancy. Gynecol Invest 1975; 6: 291-306.
19. Milewich L, Gant NF, Schwarz BE, Chen GT, Macdonald PC. Initiation of human parturition. IX. Progesterone metabolism by placentas of early and late human gestation. Obstet Gynecol 1978; 51: 278-280.
20. Milewich L, Gant NF, Schwarz BE, Chen GT, MacDonald PC. Initiation of human parturition. VIII. Metabolism of progesterone by fetal membranes of early and late human gestation. Obstet Gynecol 1977; 50: 45-48.
21. Schwarz BE, Milewich L, Gant NF, Porter JC, Johnston JM, MacDonald PC. Progesterone binding and metabolism in human fetal membranes. Ann N Y Acad Sci 1977; 286: 304-312.
22. Mickan H. Saturated metabolites of progesterone in human myometrium during pregnancy. Steroids 1976; 27: 65-77.
23. Runnebaum B, Zander J. Progesterone and 20 alpha-dihydroprogesterone in human myometrium during pregnancy. Acta Endocrinol Suppl 1971; 150: 3-45.
24. Junkermann H, Runnebaum B, Lisboa BP. New progesterone metabolites in human myometrium. Steroids 1977; 30: 1-14.
25. Leb CR, Hu FY, Murphy BE. Metabolism of progesterone by human lymphocytes: Production of neuroactive steroids. J Clin Endocrinol Metab 1997; 82: 4064-4068.
26. Parizek A, Hill M, Kancheva R et al. Neuroactive pregnanolone isomers during pregnancy. J Clin Endocrinol Metab 2005; 90: 395-403.
27. Lofgren M, Backstrom T, Joelsson I. Decrease in serum concentration of 5 alpha-pregnane-3,20-dione prior to spontaneous labor. Acta Obstet Gynecol Scand 1988; 67: 467-470.
28. Mahendroo MS, Cala KM, Russell DW. 5 alpha-reduced androgens play a key role in murine parturition. Mol Endocrinol 1996; 10: 380-392.
29. Mahendroo MS, Porter A, Russell DW, Word RA. The parturition defect in steroid 5alpha-reductase type 1 knockout mice is due to impaired cervical ripening. Mol Endocrinol 1999; 13: 981-992.
30. Milewich L, Mendonca BB, Arnhold I et al. Women with steroid 5 alpha-reductase 2 deficiency have normal concentrations of plasma 5 alpha-dihydroprogesterone during the luteal phase. J Clin Endocrinol Metab 1995; 80: 3136-3139.
31. Atherden LM. Progesterone metabolism; investigation of the products of metabolism with human liver in vitro. Biochem J 1959; 71: 411-415.
32. Kubli-Garfias C, Medrano-Conde L, Beyer C, Bondani A. In vitro inhibition of rat uterine contractility induced by 5 alpha and 5 beta progestins. Steroids 1979; 34: 609-617.
33. Thornton S, Terzidou V, Clark A, Blanks A. Progesterone metabolite and spontaneous myometrial contractions in vitro. Lancet 1999; 353: 1327-1329.
34. Perusquia M, Jasso-Kamel J. Influence of 5alpha- and 5beta-reduced progestins on the contractility of isolated human myometrium at term. Life Sci 2001; 68: 2933-2944.
35. Barnes AC, Kumar D, Goodno JA. Studies in human myometrium during pregnancy. V. Myometrial tissue progesterone analyses by gas-liquid phase chromatography. Am J Obstet Gynecol 1207; 84: 1207-1212.
36. Grazzini E, Guillon G, Mouillac B, Zingg HH. Inhibition of oxytocin receptor function by direct binding of progesterone. [comment]. Nature 1998; 392: 509-512.
37. Burger K, Fahrenholz F, Gimpl G. Non-genomic effects of progesterone on the signaling function of G protein-coupled receptors. FEBS Lett 1999; 464: 25-29.
38. Astle S, Khan RN, Thornton S. The effects of a progesterone metabolite, 5 beta-dihydroprogesterone, on oxytocin receptor binding in human myometrial membranes. BJOG 2003; 110: 589-592.
39. Bryson MJ, Sweat ML. Metabolism of progesterone in human proliferative endometrium. Endocrinology 1967; 81: 729-734.
40. Sjovall J, Sjovall K, Vihko R. Steroid sulfates in human pregnancy plasma. Steroids 1968; 11: 703-715.
41. Sheehan PM, Rice GE, Moses EK, Brennecke SP. 5beta-dihydroprogesterone and steroid 5beta-reductase decrease in association with human parturition at term. Mol Hum Reprod 2005; 11: 495-501.